Lancashire and South Cumbria
Formulary
Formulary
1 Gastro-intestinal system
01-06-07 Other drugs used in constipation
| Linaclotide Constella® |
|
Formulary
|
Capsules 290 micrograms Prescribe in line with CG61. If no improvement in symptoms at follow up then discontinue |
 LSCMMG: Linaclotide NICE CG61: Irritable bowel syndrome in adults: diagnosis and management |
|
Green restricted in West Lancashire only| Prucalopride Resolor® |
|
Formulary
|
Tablets f/c 1mg, 2mg |
|
LSCMMG: Prucalopride NICE TA211: Prucalopride for the treatment of chronic constipation in women |
|
|
Links
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Linaclotide
- LSCMMG: Primary Care Constipation Guidelines
- LSCMMG: Prucalopride
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE TA211: Prucalopride for the treatment of chronic constipation in women
- NICE TA318: Lubiprostone for treating chronic idiopathic constipation